LASHUNDRA HALL: Open Payments
NPI 1962795815 · NEW ALBANY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$172 in 7 payments from 5 companies in 2025. Trend: 2023 $103 · 2024 $18 · 2025 $172
Food & beverage: $172
| Company | Payments | Amount |
|---|---|---|
| Alpha Cognition USA, Inc. | 2 | $75 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Novo Nordisk Inc | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: Zunveyl, Qelbree, FARXIGA, BREZTRI, JARDIANCE.
Industry payments across MS — which companies pay providers there.
